CEO Message Archives

Welcome EVA Group

We are pleased to announce that the Brazilian Gynecologic Oncology Group – EVA Group– has officially joined the International Gynecologic Cancer Society’s Strategic Alliance Partner Program. Founded in 2013, EVA is a respected, mission-driven, nonprofit association dedicated to advancing gynecologic cancer care across Brazil through education, research, prevention, awareness and comprehensive patient support...

Year-End Podcast from IGCS CEO Mary Eiken

As we move through the holiday season and transition into a new year, IGCS CEO Mary Eiken reflects on the guiding principles that shape her leadership. Listen to our special year-end podcast episode to learn what grounds her: leading with gratitude, focusing on impact, and advancing equity in global cancer care...

Renew or Join

Its membership renewal season and the perfect time to join IGCS if you are not currently a member. All dues payments are applied to the 2026 membership term. IGCS provides year-round education, mentorship and training opportunities, and most recently, advocacy and outreach programming in support of our mission...

Landmark Global Study on Ovarian Cancer Published in The Lancet Obstetrics, Gynaecology & Women’s Health

We are pleased to share important news for our global community. A major new international study, “Experiences of Women with Ovarian Cancer in 22 Low- and Middle- Income Countries (Every Woman Study™ LMIC): a Cross-sectional Study,” was published today in the The Lancet Obstetrics, Gynaecology, & Women’s Health...

Position Paper: Spotlight on Uterine Cancer

Uterine cancer is the second most common gynecological cancer globally, but often it is missing from national cancer plans and global health priorities. Without political attention, there is no accountability, no funding, and no progress. The position paper on uterine cancer “Spotlight on uterine cancer: Shaping access to equitable and high-quality care”, which IGCS co-authored with like-minded organizations from around the world, including AstraZeneca, is a call to governments and policymak..

Exciting Changes Ahead for the IGCS Early Career Professionals Network

Exciting changes are underway for the IGCS Early Career Professionals Network, including a broader global platform for mentorship, leadership development, education, and connection, with a new member-led governance structure. ..

Introducing IGCS ACCESS Series

Introducing the ACCESS Series Beginning in 2025, IGCS will host an ACCESS Series alongside the upcoming IGCS Annual Global Meeting. As IGCS circulates around the world, each symposium will highlight priorities, challenges, and solutions specific to the region in which the meeting is being held...

Insights on IGCS’ Identity: Board Members Weigh In

What does it mean to belong to the International Gynecologic Cancer Society? Who are we today, and where are we headed? These are the questions I’ve been reflecting on—not only as CEO, but as someone who has had the privilege of working alongside countless clinicians, advocates, and global health champions who have built IGCS into what it is today. Read IGCS CEO, Mary Eiken's, latest message. ..

IGCS Welcomes AGOI as a Strategic Alliance Partner

We are pleased to welcome the Association of Gynecologic Oncologists of India (AGOI) as the newest member of the IGCS Strategic Alliance Partner Program...

IGCS welcomes Kenyan Society to Strategic Alliance Partner Program

We are delighted to announce that the recently formed Gynecologic Oncology Society of Kenya (GOSK) has officially become a part of the International Gynecologic Cancer Society’s Strategic Alliance Partner Program. Founded on 14th June 2023, GOSK was established to unite healthcare professionals, researchers, and advocates with a shared vision of improving the quality of care for women affected by gynecologic cancers in Kenya...